Globus Medical (GMED) Receivables (2016 - 2025)
Globus Medical (GMED) has disclosed Receivables for 15 consecutive years, with $678.9 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Receivables rose 21.74% year-over-year to $678.9 million, compared with a TTM value of $678.9 million through Dec 2025, up 21.74%, and an annual FY2025 reading of $678.9 million, up 21.74% over the prior year.
- Receivables was $678.9 million for Q4 2025 at Globus Medical, up from $619.1 million in the prior quarter.
- Across five years, Receivables topped out at $678.9 million in Q4 2025 and bottomed at $159.6 million in Q3 2021.
- Average Receivables over 5 years is $381.3 million, with a median of $367.1 million recorded in 2023.
- The sharpest move saw Receivables soared 154.71% in 2024, then decreased 0.04% in 2025.
- Year by year, Receivables stood at $164.4 million in 2021, then grew by 29.68% to $213.2 million in 2022, then skyrocketed by 135.99% to $503.2 million in 2023, then increased by 10.82% to $557.7 million in 2024, then increased by 21.74% to $678.9 million in 2025.
- Business Quant data shows Receivables for GMED at $678.9 million in Q4 2025, $619.1 million in Q3 2025, and $611.6 million in Q2 2025.